Preeclampsia (pe) Clinical Trials
3 recruiting trials for Preeclampsia (pe). Eligibility criteria explained in plain English.
TrialFinderData lists 3 Preeclampsia (pe) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1), Institute of Health Information and Statistics of the Czech Republic (1), Heidelberg University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Hyperspectral imaging (diagnostic_test, 1 trial), followed by Further markers of endothelial dysfunction.
Track Preeclampsia (pe) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications
In this project, the investigators aim to study how all these factors determine the cardiovascular status of a total of 1,800 mothers, 3 to 6 years after delivery. In addition,...
The Combined First Trimester Screening
The project is a national, prospective, multicenter pilot project. The project is focus on setting up the combined first trimester screening in the Czech Republic. The combined...
Endothelial Dysfunction for Prognosis In Patients With preeClampSia
Preeclampsia is a pregnancy-specific hypertensive disorder and can progress rapidly to severe adverse outcomes affecting both the mother and the fetus. Endothelial and...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Preeclampsia (pe), with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Preeclampsia (pe), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Preeclampsia (pe), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.